Literature DB >> 9051752

Bilateral ischemic tolerance of rat hippocampus induced by prior unilateral transient focal ischemia: relationship to c-fos mRNA expression.

L Belayev1, M D Ginsberg, O F Alonso, J T Singer, W Zhao, R Busto.   

Abstract

The purpose of this study was to determine whether transient unilateral (2 h) middle cerebral artery occlusion (MCAo) is capable of inducing bilateral ischemic tolerance in hippocampal CA1 neurons when temporary bilateral forebrain ischemia by two-vessel occlusion (2VO) is carried out 3 days later, and to explore the relationship of this tolerance to the regional expression of c-fos and hsp-70 mRNA. Rats were sacrificed 4 days after 2VO, and normal-appearing neurons in CA1 subregions were counted. Rats subjected to MCAo and 2VO showed significant protection of CA1 neurons in both hippocampi, whereas rats which underwent sham MCAo and 2VO typically had severe bilateral destruction of CA1 neurons (normal neuron counts, ipsilateral medial CA1: 59.8 +/- 7.2 vs 16.6 +/- 7.8 (mean +/- s.e.m.); middle CA1: 50.0 +/- 4.7 vs 16.0 +/- 8.8; lateral CA1: 43.5 +/- 5.7 vs 13.8 +/- 6.3; contralateral, medial CA1: 52.3 +/- 6.3 vs 17.0 +/- 6.4; middle CA1: 43.3 +/- 4.7 vs 19.8 +/- 8.1; lateral CA1: 45.5 +/- 4.6 vs 26.0 +/- 10.3, respectively). This neuronal tolerance was preceded by the early bilateral induction of c-fos mRNA, which may in turn lead to expression of critical target genes that promote cell recovery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9051752     DOI: 10.1097/00001756-199612200-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Oligodendrocyte degeneration and recovery after focal cerebral ischemia.

Authors:  S R McIver; M Muccigrosso; E R Gonzales; J M Lee; M S Roberts; M S Sands; M P Goldberg
Journal:  Neuroscience       Date:  2010-05-31       Impact factor: 3.590

Review 2.  Maternal infection and white matter toxicity.

Authors:  G Jean Harry; Cindy Lawler; Susan H Brunssen
Journal:  Neurotoxicology       Date:  2006-05-17       Impact factor: 4.294

3.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21

4.  Gemfibrozil pretreatment resulted in a sexually dimorphic outcome in the rat models of global cerebral ischemia-reperfusion via modulation of mitochondrial pro-survival and apoptotic cell death factors as well as MAPKs.

Authors:  Fatemeh Mohagheghi; Abolhassan Ahmadiani; Behrouz Rahmani; Fatemeh Moradi; Nathalie Romond; Leila Khalaj
Journal:  J Mol Neurosci       Date:  2013-01-05       Impact factor: 3.444

Review 5.  Cellular and molecular neurobiology of brain preconditioning.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Mol Neurobiol       Date:  2009-01-20       Impact factor: 5.590

6.  Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats.

Authors:  Yoshiteru Soejima; Robert P Ostrowski; Anatol Manaenko; Mutsumi Fujii; Jiping Tang; John H Zhang
Journal:  Med Gas Res       Date:  2012-04-11

7.  GAS6/Axl Signaling Modulates Blood-Brain Barrier Function Following Intravenous Thrombolysis in Acute Ischemic Stroke.

Authors:  Zhen-Ni Guo; Jie Liu; Junlei Chang; Peng Zhang; Hang Jin; Xin Sun; Yi Yang
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

8.  Delayed postconditioning protects against focal ischemic brain injury in rats.

Authors:  Chuancheng Ren; Xuwen Gao; Gang Niu; Zhimin Yan; Xiaoyuan Chen; Heng Zhao
Journal:  PLoS One       Date:  2008-12-10       Impact factor: 3.240

9.  Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury.

Authors:  Ferah Yildirim; Shengbo Ji; Golo Kronenberg; Angel Barco; Roman Olivares; Eva Benito; Ulrich Dirnagl; Karen Gertz; Matthias Endres; Christoph Harms; Andreas Meisel
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.